Substantial derangements of mesothelial biology are observed during experimental simulations of dialysis conditions, inferred from the content of human dialysis effluent and visualized by microscopy of human mesothelial biopsies. Canosmotically active solutions be made biocompatible with the osmoregulatory system of the mesothelium? Can the contributions of the mesothelium to host defenses against inflammation and/or infection be supported during CAPD? Do underlying metabolic derangements present in various kidney diseases and end-stage renal disease, regardless of cause, require customized CAPD protocols and solutions? Use of dialysis solutions less directly toxic to the mesothelium is a necessary step toward some day manipulating peritoneal biology by pharmacological and therapeutic modalities.
DobbieJ.W.Morphofunctional correlations in human mesothelium. In: Peritoneal dialysis.LaGrecaG., ed. Milano: Wichtig Editore, 1991: 33–43.
3.
DobbieJ.W.New concepts in molecular biology and ultrastructural pathology of the peritoneum: their significance for peritoneal dialysis.Am J Kidney Dis1990; 15: 97–109.
4.
DobbieJ.W.Pathogenesis of peritoneal fibrosing syndrome (sclerosing peritonitis) in peritoneal dialysis.Perit Dial Int1992; 12: 14–27.
5.
DobbieJ.W.Serositis: comparative analysis of histological findings and pathogenetic mechanisms in nonbacterial serosal inflammation.Perit Dial Int1993; 13: 256–69.
TopleyN., WilliamsJ.D.Role of the peritoneal membrane in the control of inflammation in the peritoneal cavity.Kidney Int1994; 46(Suppl 48): S71–8.
8.
ConnellN.D., RheinwaldJ.G.Regulation of the cytoskeleton in mesothelial cells: reversible loss of keratin and increase in vimentin during rapid growth in culture.Cell1983; 34: 245–53.
9.
PronkA., LeguitP., Hoynckvan PapendrechtA.A.A cobblestone cell isolated from the human omentum: the mesothelial cell; isolation, identification, and growth characteristics.In Vitro Cell Dev Biol1993; 29A: 127–34.
10.
FougerayS., SlingeneyerA., BastideM.Validity of human peritoneal mesothelial cell cultures: peritoneal biopsies from ESRD and non-ESRD patients.Perit Dial Int1994; 14(Suppl 1): S85.
11.
DimkovicN.B., BarjaktarovicN.M., KosticV.M.Cytogenetic analyses reveal atypical cells in the peritoneal dialysis effluent.Perit Dial Int1994; 14: 159–62.
PannekeetM.M., KoomenG.C.M., StruijkD.G.Dialysate CA125 in stable CAPD patients: no relation with transport kinetics.Perit Dial Int1995; 15(Suppl 1): S13.
ZeillemakerA.M., Hoynck van PapendrechtAAGM, RossD.Preferential apical secretion of IL-6 and IL-8 by stimulated human mesothelial cells.Perit Dial Int1993; 13(Suppl 1): S30.
19.
ZeillemakerA.M., VerbrughH.A., Hoynck van PapendrechtAAGMCA125 secretion by peritoneal mesothelial cells.J Clin Pathol1994; 47: 263–5.
20.
GotloibL., ShostakA., WajsbrotV.Biocompatibility of dialysis solutions evaluated by histochemical techniques applied to mesothelial cell imprints.Perit Dial Int1993; 13(Suppl 2): Sl13–15.
CantyD.J., ZeiselS.H.Lecithin and choline in human health and disease.Nutr Rev1994; 52: 327–39.
23.
HjelleJ.T., WelchM.H., PavlinaT.M.Choline levels in human peritoneal dialysate. In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G., eds. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Publications, 1993; 9: 299–302.
24.
BreborowiczA., WitowskiJ., KnapowskiJ.Invitro study of the mechanism of potassium transport into human mesothelial cells. I: Effect of hyperosmolality.Perit Diallnt1993; 13: 201–7.
25.
GrahameG.R., TorchiaM.G., DankewichK.A.Surface active material in peritoneal effluent of CAPD patients.Perit Dial Bull1985; 5: 109–11.
26.
DobbieJ.W., PavlinaT., LloydJ.Phosphatidylcholine synthesis by peritoneal mesothelium: its implications for peritoneal dialysis.Am J Kidney Dis1988; 12: 31–6.
27.
DiPaoloN., BuoncristianiU., CapotondoL.Phosphatidylcholine and peritoneal transport during peritoneal dialysis.Nephron1986; 44: 365–70.
28.
HjelleJ.T., SteidleyK.R., PavlinaT.M.Choline incorporation into phospholipids in mesothelial cells in vitro.Perit Dial Int1993; 13: 289–95.
29.
BeavisJ., HarwoodJ.L., ColesG.A.Synthesis of phospholipids by human peritoneal mesothelial cells.Perit Dial Int1994; 14: 348–55.
30.
HillsB.A., ButlerB.D., BarrowR.E.Boundary lubrication imparted by pleural surfactants and their identification.J Appl Physiol1982; 53: 463–9.
31.
LloydJ.K., DobbieJ.W., HauckW.N.Localization of surfactant phospholipids in the peritoneal mesothelium. In: BaileyG.W., ed. Proceedings of the 46th Annual Meeting Electron Microscopy Society of America.San Francisco Press1988: 142–3.
32.
DobbieJ.W.Ultrastructural similarities between mesothelium and type II pneumocytes and their relevance to phospholipid surfactant production by the peritoneum. In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G., eds. Advances in CAPD.Toronto: Peritoneal Dialysis Bulletin, 1988; 4: 32–41.
33.
HjelleJ.T., GolinskaB.T., WatersD.C.In vivo and in vitro characterization of mesothelial lipid inclusions.Perit Dial Int1991; 11: 207–12.
34.
AndrewsP.M., PorterK.R.The ultrastructural morphology and possible functional significance of mesothelial microvilli.Anat Rec1973; 177: 409–26.
35.
MaherJ.F.Lubrication of the peritoneum.Perit Dial Int1992; 12: 346–9.
36.
VoelkerD.R.Organelle biogenesis and intracellular lipid transport in eukaryotes.Microbiol Rev1991; 55: 543–60.
HjelleJ.T., GolinskaB.T., WatersD.C.Lectin staining of peritoneal mesothelial cells in vitro.Perit Dial Int1991; 11: 307–16.
39.
RooneyS.A., YoungS.L., MendelsonC.R.Molecular and cellular processing of lung surfactant.F ASEB J1994; 8: 957–67.
40.
DobbieJ.W., TasiauxN., MeijersP.Lamellar bodies in synoviocytes, mesothelium and specific epithelia as possible site of auto-antigen in rheumatoid disease.Br J Rheumatol1994; 33: 508–19.
41.
BatesS.R., DodiaC., FisherA.B.Surfactant protein A regulates uptake of pulmonary surfactant by lung type II cells on microporous membranes.Am J Physiol1994; 267: L753–60.
42.
HomskovU., MalhotraR., SimR.B.Collectins: collagenous C-type lectins of the innate immune defense system.Immunol Today1994; 15: 67–74.
CoeneM.C., SolheidC., ClaeysM.Prostaglandin production by cultured mesothelial cells.Arch Int Pharmacodyn Ther1981; 249: 316–18.
45.
CoeneM.C., van HoveC., ClaeysM.Arachadonic acid metabolism by cultured mesothelial cells. Different transformations of exogenously added and endogenously released substrate.Biochem Biophys Acta1982; 710: 437–45.
46.
BultH., CoeneM.C., RampartM.Complement derived factors and prostacyclin formation by rabbit isolated peritoneum and cultured mesothelial cells.Agents Actions Suppl1984; 14: 237–47.
47.
van de VeldV.J.S., HermanA.G., BultH.Effects of dexamethasone on prostaglandin biosynthesis in rabbit mesothelial cells.Prostaglandins1986; 32: 169–78.
48.
TopleyN., PetersenM.M., MackenzieR.Human peritoneal mesothelial cell prostaglandin synthesis: induction of cyclooxygenase mRNA by peritoneal macrophage-derived cytokines.Kidney Int1994; 46: 900–9.
49.
SteinhauerH.B., SchollmeyerP.Prostaglandin mediated loss of proteins during peritonitis in continuous ambulatory peritoneal dialysis.Kidney Int1986; 29: 584–90.
50.
MayerR.J., MarshallL.A.New insights on mammalian phospholipase A2(s); comparison of archidonoyl-selective and -nonselective enzymes.FASEB J1993; 7: 339–48.
51.
DiPaoloN., SacchiG., VanniL.Implant of autologous mesothelial cells in animals and a peritoneal dialysis patient.Int J Artif Organs1989; 12: 485–501.
52.
CarozziS., LamperiS.Activation of peritoneal mesothelial cells, marcrophages and polymorphonuclears and peritoneal dialysis effluent cytokines during peritonitis in CAPD.Perit Dial Int1994; 14(Suppl 1): S42.
53.
MortonA.R., PierratosA., VadasP.Phospholipase A2 and interleukin-l bioactivity in peritoneal dialysis patients.Perit Dial Int1991; 11(Suppl 1): 184.
54.
SteinbrecherU.P., PritchardP.H.Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase.J Lipid Res1989; 30: 305–15.
55.
TakashiK., HataJ., MukaiK.Close similarity between cultured human omental mesothelial cells and endothelial cells in cytochemical markers and plasminogen activator production.In Vitro Cell Dev Biol1991; 27A: 542–8.
56.
KreigerM., HerzJ.Structures and functions of multiligand lipoprotein receptor-related protein.Ann Rev Biochem1994; 63: 601–37.
57.
BellazziR., MaggiE., BellomoG.Low-density lipoprotein oxidation and antioxidized LDL antibodies in peritoneal dialysis patients. In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G., eds. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Publications, 1993; 9: 312–17.
HannunY.A.The sphingomyelin cycle and the second messenger function of ceramide.J Biol Chem1994; 269: 3125–8.
60.
NakamuraT., AbeA., BalazovichK.J.Ceramide regulates oxidant release in adherent human neutrophils.J Biol Chem1994; 269: 18384–9.
61.
GotloibL., ShustocA., JaichenckoJ.Loss of mesothelial electromagnetic fixed charges during murine spetic peritonitis.Nephron1989; 51: 77–83.
62.
YungS., ColesG.A., WilliamsJ.D.The source and possible significance of hyaluronan in the peritoneal cavity.Kidney Int1994; 46: 527–33.
63.
MahioutA., GotzE., ReinhardB.Intraperitoneal accumulation of advance glycosylation end products in CAPD patients.Perit Dial Int1995; 15(Suppl 1): S78.
64.
MahioutA., BrunkhorstR.Human mesothelial cells produce 72kD-gelatinase during exposure to advanced glycosylated (AGE) collagen.Perit Dial Int1995; 15(Suppl 1): S11.
65.
DigenisG.E., DombrosN.V., BalaskasE.V.Procollagen-l andcollagen-l in the serum and dialysate of CAPD patients. Changes over time.Perit Dial Int1995; 15(Suppl 1): S52.
66.
KumanoK., ManalaysayM.T., HyodoT.Inhibition of peritoneal mesothelial cell growth by glycosylated albumin.Perit Dial Int1995; 15(Suppl 1): S68.
67.
Grulich-HennJ., PreissnerK.T., Muller-BerghausG.Heparin stimulates fibrinolysis in mesothelial cells by selective induction of tissue-plasminogen activator but not plasminogen activator inhibitor-l synthesis.Thromb Haemostas1990; 64: 420–5.
68.
van HinsberghV.W., KooistraT., SchefferM.A.Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells.Blood1990; 75: 1490–7.
69.
LinJ.J., SignhalK., PartonL.Correlations between plasminogen activatorinhibitor-l and peritoneal transport in pediatric patients.Perit Dial Int1994; 14(Suppl 1): S25.
70.
SelgasR., CuestaM.V., RinonC.Tissue plasminogen activator and plasminogen activator inhibitor-llevels in plasma and peritoneal effluentin patients on CAPD. In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G., eds. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Bulletin, 1992; 8: 160–5.
71.
MarianoF., TettaC., MontrucchioG.Role of α 1 proteinase inhibitor in restraining peritoneal inflammation in CAPD patients.Kidney Int1992; 42: 735–42.
72.
KoomenG.C.M., BetjesM.G.H., ZemelD.Cancer antigen 125 is locally produced in the peritoneal cavity during continuous ambulatory peritoneal dialysisPerit Dial Int1994; 14: 132–6.
73.
Dagogo-JackS., RodgerR.S.C., Kendall-TaylorP.In creased salivary concentration of human epidermal growth factor in patients undergoing CAPD.Perit Dial Int1991; 11: 270–3.
74.
BreborowiczA., BalaskasE.V., DiamadnisE.Effect of tumor necrosis factor on human mesothelial cells in in vitro culture.Perit Dial Int1992; 12(Suppl 1): S6.
75.
JosephC.K., WrightS.D., BornmannW.G.Bacterial lipopolysaccharide has structural similarity to ceramide and stimulates ceramide-activated protein kinase in myeloid cells.J Biol Chem1994; 269: 17606–10.
76.
HanJ., LeeJ-D, BibbsL.A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells.Science1994; 265: 808–11.
BreborowiczA., RodelaH., OreopoulosD.G.Toxicity of osmotic solutes on human mesothelial cells in vitro.Kidney Int1992; 41: 1280–5.
84.
WitowskiJ., TopleyN., JörresA.Effect of lactate-buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis.Kidney Int1994; 46: 282–93.
HarveyW., AmlotP.L.Collagen production by human mesothelial cells in vitro.J Pathol1983; 139: 337–47.
87.
DaviesM., StylianouE., YungS.Proteoglycans of CAPD-dialysate and mesothelium. In: ColesG.A., DaviesM., WilliamsJ.D., eds. CAPD: host defence, nutrition and ultrafiltration.Contrib Nephrol, Basel, Karger, 1990; 85: 134–41.
88.
CantorJ.O., WilliteM., BrayB.A.Synthesis of crosslinked elastin by a mesothelial cell culture.Proc Soc Exp Biol Med1986; 181: 387–91.
89.
KumanoK., Schiller-MoranB., HjelleJ.T.Hypertonic glucose decreases total protein synthesis but increases fibronectin gene expression on cultured rat mesothelial cells.Perit Dial Int1994; 14(Suppl 1): S5.
90.
JonjicN., PeriG., BernasconiS.Expression of adhesion molecules and chemotaxic cytokines in cultured human mesothelial cells.J Exp Med1992; 176: 1165–74.
91.
ZeillemakerA.M., Hoynck van PapendrechtAAGM, RossD.Neutrophil adherence to and migration through human mesothelial cell monolayers.Perit Dial Int1993; 13(Suppl 1): S30.
92.
TopleyN., LiberekT., LuttmannW.ICAM-l expression by human peritoneal mesothelial cells: role in PMN transmigration.Perit Dial Int1994; 14(Suppl 1): S74.
KumanoK., SchillerB., HjelleJ.T.Effects of high glucose on cell proliferation and TGF-β expression in cultured rat mesothelial cells (Abstract).J Am Soc Nephrol1993; 4: 410.
GoodmanR.B., WoodR.G., MartinT.R.Cytokinestimulated human mesothelial cells produce chemotactic activity for neutrophils including NAP/IL-8.J Immunol1992; 148: 457–65.
99.
BetjesM.G.H., TukC.W., StruijkD.G.Interleukin 8 production by human peritoneal mesothelial cells in response to tumor necrosis factorα, interleukin-l, and medium conditioned by macrophages co-cultured with Staphylococcus epidermidis.J Infect Dis1993; 168: 1202–10.
100.
DemetriG.D., ZenaieB.W., RheinwaldJ.G.Expression of colony-stimulating factor genes by normal human mesothelial cells and human malignant mesothelioma celllinesin vitro.Blood1989; 74: 940–6.
101.
Haag-WeberM., HorlW.H.Impact of continuous ambulatory peritoneal dialysis solutions and clearance of macromolecules on polymorphonuclear neutrophils.Perit Dial Int1994; 14(Suppl 3): S33–8.
102.
GabrielsonE.W., GerwinB.I., HarrisC.C.Stimulation of DNA synthesis in cultured primary human mesothelial cells by specific growth factors.FASEB J1988; 2: 2717–21.
103.
WuY-J, ParkerL.M., BinderN.E.The mesothelial keratins: a new family of cytoskeletal proteins identified in cultured mesothelial cells and nonkeratinizing epithelia.Cell1982; 31: 693–703.
104.
WitowskiJ., BreborowiczA., KnapowskiJ.Insulin modifies the function of human peritoneal mesothelial cells.Perit Dial Int1994; 14(Suppl 1): S12.
105.
UchiyamaA., KitsukiH., ShimuraH.Suppression by interferon-gamma of tumor cell-induced increase in mesothelial permeability.Clin Exp Metastasis1992; 10: 371–8.
106.
HjelleJ.T., HoA.K.S., DobbieJ.W.Evidence of muscarinic acetylcholine receptors and GTP-binding proteins in peritoneal mesothelia cells in vitro. In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G., eds. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Publications, 1993; 9: 303–6.
107.
HjelleJ.T., HoA.K.S., DobbieJ.W.Binding of muscarinic drugs to mesothelial cells is altered by several drug classes and hyperosmolarity.Perit Dial Int1995; 15(Suppl): S10.
